RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions

Rhea-AI Summary

Regenerative Medical Technology Group (OTCID:RMTG) announced details for its inaugural investor call addressing shareholder-submitted questions, following what it describes as a strong first half of 2026. Management will deliver prepared remarks without a live Q&A or discussion of second quarter 2026 financial results.

Event: RMTG Investor Call – Shareholder Questions. Date: Thursday, August 20, 2026. Time: 5:00–6:00 p.m. Eastern Time (America/New York). Format: Google Meet video call via the published link. According to RMTG, further updates on growth initiatives and operating performance will follow in subsequent releases, and investors are encouraged to review filings on the SEC website.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Company Announces Date, Time and Connection Details for Its Inaugural Investor Call Following a Strong First Half of 2026

MIAMI, FL / ACCESS Newswire / August 19, 2026 / Regenerative Medical Technology Group, Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, today announced the connection details for its first-ever investor call, during which management will present prepared remarks responding to questions submitted by shareholders. The call reflects the Company's strong performance through the first half of 2026 and management's commitment to increased transparency and engagement with its shareholders.

As previously announced, the call will feature prepared remarks based on questions received from shareholders and will not include a live question-and-answer session or a discussion of the Company's second quarter 2026 financial results.

How to Join the Call

Event: RMTG Investor Call - Shareholder Questions

Date: Thursday, August 20, 2026

Time: 5:00 - 6:00 p.m. Eastern Time (America/New York)

Format: Google Meet video call

Link: https://meet.google.com/sta-drko-iaf

"We have received many thoughtful questions from our shareholders and investors, and we look forward to addressing them," said David Christensen, CEO and President of RMTG. "We are encouraged by RMTG's progress and remain focused on executing in the dynamic and rapidly evolving field of regenerative medicine."

The Company expects to provide additional updates on its growth initiatives and operating performance in subsequent releases and encourages investors and interested parties to review the Company's filings at www.sec.gov.

About Regenerative Medical Technology Group, Inc.

Regenerative Medical Technology Group, Inc. (OTCID:RMTG) is a regenerative medicine company operating through Global Stem Cells Group and its subsidiaries, combining physician education, laboratory operations, biologics manufacturing, product commercialization, and digital healthcare Technology across an international network. The Company operates across more than 30 countries. Additional information about the Company's business, operations, and risks is available in its filings with the Securities and Exchange Commission.

Forward-Looking Statements

This press release contains forward-looking statements. These statements include, but are not limited to, the anticipated timing and holding of the Company's first investor call, the format of the call, and any statements regarding the Company's plans, expectations, or intentions with respect to the call or related disclosures. Forward-looking statements are based on management's current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks and uncertainties include, among others, the Company's ability to continue as a going concern, liquidity and capital resource constraints, substantial debt obligations and the risk of acceleration of such debt, regulatory developments and compliance requirements in the United States, Argentina and other jurisdictions, market acceptance of the Company's products and services, operational execution risks, competitive conditions, and the other risks described in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and in its subsequent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact:
Investor Relations
Regenerative Medical Technology Group, Inc.
ir@rmtg.com | (800) 956-3935

SOURCE: Regenerative Medical Technology Group, Inc.

View the original press release on ACCESS Newswire

FAQ

When is the first RMTG (OTCID:RMTG) investor call to answer shareholder questions?

RMTG’s first investor call for shareholder questions is scheduled for Thursday, August 20, 2026, from 5:00 to 6:00 p.m. Eastern Time. According to RMTG, the event will feature prepared remarks from management based on questions submitted in advance by shareholders.

How can investors join the RMTG investor call on August 20, 2026?

Investors can join the RMTG investor call via a Google Meet video link: https://meet.google.com/sta-drko-iaf. According to RMTG, the call will run from 5:00 to 6:00 p.m. Eastern Time and will focus on pre-submitted shareholder questions.

Will RMTG discuss Q2 2026 financial results during its August 20, 2026 investor call?

RMTG does not plan to discuss its second quarter 2026 financial results during this call. According to RMTG, the event will consist of prepared remarks responding to previously submitted shareholder questions, with no live question-and-answer session.

Will there be a live Q&A session during the RMTG (OTCID:RMTG) investor call?

There will be no live Q&A session during the RMTG investor call. According to RMTG, management will answer questions only through prepared remarks based on shareholder submissions received before the event, without real-time interaction.

What topics does RMTG plan to address during its inaugural investor call?

RMTG plans to address shareholder-submitted questions and comment on its progress in regenerative medicine. According to RMTG, prepared remarks will reflect its strong first half of 2026, but will exclude second quarter 2026 financial results discussion and live Q&A.

Where can investors find more information about RMTG’s business and risks?

Investors can find information on RMTG’s business, operations, and risks in its filings on www.sec.gov. According to RMTG, additional updates on growth initiatives and operating performance are expected in subsequent company releases beyond this investor call.